Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MENDS2: Dexmedetomidine vs Propofol in Sepsis
NCT01739933Phase 3Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2013
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in sepsis, delirium and cognitive impairment, sponsored by Vanderbilt University Medical Center. Primary endpoint: Delirium/Coma Free Days at 14 days. Started May 2013; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
sepsisdeliriumcognitive impairment
Beyond the preview
Go deeper on NCT01739933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739933.